COVID-19 vaccine-related lymphadenopathy may affect breast screening

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
News Item
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954685/
http://dx.doi.org/10.1007/s40278-021-92249-y
_version_ 1783664125615800320
collection PubMed
description
format Online
Article
Text
id pubmed-7954685
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-79546852021-03-15 COVID-19 vaccine-related lymphadenopathy may affect breast screening Reactions Weekly News Item Springer International Publishing 2021-03-13 2021 /pmc/articles/PMC7954685/ http://dx.doi.org/10.1007/s40278-021-92249-y Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
COVID-19 vaccine-related lymphadenopathy may affect breast screening
title COVID-19 vaccine-related lymphadenopathy may affect breast screening
title_full COVID-19 vaccine-related lymphadenopathy may affect breast screening
title_fullStr COVID-19 vaccine-related lymphadenopathy may affect breast screening
title_full_unstemmed COVID-19 vaccine-related lymphadenopathy may affect breast screening
title_short COVID-19 vaccine-related lymphadenopathy may affect breast screening
title_sort covid-19 vaccine-related lymphadenopathy may affect breast screening
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954685/
http://dx.doi.org/10.1007/s40278-021-92249-y

Ejemplares similares